1-(5-isoquinolinesulfonyl)piperazine,
C-I-QP,
84468-24-6,
1-(5-Isoquinolinesulfonyl)piperazine,
HA 100 (pharmaceutical),
5-(piperazin-1-ylsulfonyl)isoquinoline,
5-piperazin-1-ylsulfonylisoquinoline,
C-1,
1-(5-Isoquinolinylsulfonyl)piperazine,
CHEMBL75773,
Isoquinoline,5-(1-piperazinylsulfonyl)-,
Piperazine, 1-(5-isoquinolinylsulfonyl)-,
C13H15N3O2S,
IQSP,
Tocris-0543,
AC1Q6UWL,
C-I-QP,
AC1L1G6E,
isoquinoline-5-sulfonamide 18,
SCHEMBL1272907,
BDBM15203,
CHEBI:93271,
CTK5F2377,
BRD2751,
DTXSID60233438,
UPTYCYWTFGTCCG-UHFFFAOYSA-N,
HA100,
HMS3266K06,
HMS3675C20,
BRD-2751,
HA 100,
ZINC35024805,
1-(5-isoquinolinesulfonyl) piperazine,
5-(piperazine-1-sulfonyl)isoquinoline,
AKOS009604745,
1-(5-Isoquinolinylsulfonyl)-piperazine,
NCGC00024641-01,
AN-35909,
HY-100984,
LS-112734,
B6343,
CS-0020664,
Isoquinoline-5-sulfonic acid piperazin-1 ylamide,
SR-01000597700,
1-(5-Isoquinolinesulfonyl)piperazine,dihydrochloride,
SR-01000597700-1,
BRD-K72462751-001-01-9,
ha-100,
CID3545,
1- PIPERAZINE,DIHYDROCHLORIDE,
AR-1G5690,
C13-H15-N3-O2-S,
1-(5-Isoquinolinesulfonyl)piperazine hydrochloride,
903-17-3,